Prosus (ENXTAM:PRX) Could Be 13% Undervalued On Board Committee Reshuffle

Prosus (ENXTAM:PRX) has reshuffled its board committees, with new appointments to both the audit and risk groups, after confirming that each now has enough directors to carry out its oversight roles.

Prosus shares, which last closed at €35.76, have come under pressure, with a 1-day share price return that declined 4.82% and a year-to-date share price return down 33.54%. At the same time, the 3-year total shareholder return of 30.17% and 5-year total shareholder return of 13.48% point to a mixed longer-term picture as investors weigh these governance updates against past value creation.

Spot opportunities beyond Prosus by scanning a curated 177 high quality undervalued stocks that may offer stronger balance sheets and more resilient return profiles in the current market.

Prosus now trades well below the average analyst target, even after the latest governance reshuffle and share price drop. Does fair value sit closer to the current €35 level, or nearer the €61 consensus range?

Most Popular Narrative: 13% Undervalued

Prosus closed at €35.76, while the most followed narrative pegs fair value nearer €41.12, so the tension sits squarely between discounted share price and execution risk in classifieds and AI monetisation.

The company's continued M&A activity, including major transactions in Just Eat and Despegar, heightens risk that significant capital will be allocated to geographies or segments beset by competitive intensity, macro volatility, or integration challenges, including overlapping regulatory regimes, which could result in lower-than-expected returns, delayed profitability, and ongoing margin pressure.

See why 5 investors see Prosus as 13% undervalued.

Result: Fair Value of €41.12 (UNDERVALUED)

Still, if Prosus turns stronger AI adoption and tighter cost discipline into faster margin progress, this bearish fair value narrative could be tested quickly.

Find out about the key risks to this Prosus narrative.

Another View on Prosus: DCF Flips the Story

The analyst narrative tags Prosus as undervalued around €41 based on earnings assumptions and P/E, yet the SWS DCF model paints a very different picture. On that future cash flow view, Prosus at €35.76 screens as expensive versus an estimated value of €15.43.

This gap between earnings based upside and DCF implied downside raises a simple question for you as a shareholder: Which set of assumptions about future cash generation feels closer to how Prosus is actually run and funded?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Prosus for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 177 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed signals around Prosus can be frustrating, so look at the numbers yourself and decide where the balance of risk and upside really sits. To frame that decision quickly with both sides of the story, review the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Prosus?

Do not stop your research with Prosus when a wider watchlist can help you spot fresher opportunities and avoid concentrating risk in a single position.

• Target potential mispricings by reviewing companies on the 177 high quality undervalued stocks that might align better with your preferred quality and return profile.
• Strengthen portfolio resilience by scanning a list of solid balance sheet and fundamentals (199 results) so you can focus on businesses with healthier finances.
• Unearth fresh opportunities by checking a 618 high quality undiscovered gems that might not yet be crowded with other investors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com